Veracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.14), $0.12 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $17.49 million.

Veracyte expects to achieve the following results in 2017:

• Annual revenue in the range of $76 to $84 million; and
• Annual cash burn of $25 to $27 million, a reduction of 16 to 22% over the prior year.

For earnings history and earnings-related data on Veracyte (VCYT) click here.